SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
12-Oct-21 9:43 AM View: | Surgalign Holdings, Inc. (SRGA) | 10-Oct-21 | Payment of Exercise | 9,796 | $1.04 | $10,187.80 | (1%) 929.52K to 919.73K | < 1% |
10-May-21 4:59 PM View: | Surgalign Holdings, Inc. (SRGA) | 07-May-21 | Grant | 380,735 | -- | -- | 69% 548.78K to 929.52K | |
12-Apr-21 2:00 PM View: | Surgalign Holdings, Inc. (SRGA) | 10-Apr-21 | Payment of Exercise | 9,796 | $2.05 | $20,081.80 | (2%) 558.58K to 548.78K | 0% |
02-Mar-21 3:05 PM View: | Surgalign Holdings, Inc. (SRGA) | 28-Feb-21 | Payment of Exercise | 5,685 | $2.44 | $13,871.40 | (1%) 564.27K to 558.58K | (20%) |
02-Mar-21 3:05 PM View: | Surgalign Holdings, Inc. (SRGA) | 26-Feb-21 | Payment of Exercise | 5,361 | $2.44 | $13,080.80 | (< 1%) 569.63K to 564.27K | (20%) |
28-Feb-20 5:14 PM View: | Surgalign Holdings, Inc. (SRGA) | 28-Feb-20 | Payment of Exercise | 5,510 | $3.70 | $20,387.00 | (< 1%) 575.14K to 569.63K | 31% |
28-Feb-20 5:14 PM View: | Surgalign Holdings, Inc. (SRGA) | 26-Feb-20 | Payment of Exercise | 5,940 | $4.05 | $24,057.00 | (1%) 581.08K to 575.14K | 37% |
14-Jan-20 5:11 PM View: | Surgalign Holdings, Inc. (SRGA) | 10-Jan-20 | Grant | -- | -- | -- | 0% -- | |
11-Mar-19 5:02 PM View: | RTI Biologics, Inc. (RTIX) | 08-Mar-19 | Disposition | 313,630 | -- | -- | (100%) 313.63K to 0 | |
11-Mar-19 5:16 PM View: | Surgalign Holdings, Inc. (SRGA) | 08-Mar-19 | Grant | 313,630 | -- | -- | 100% 0 to 313.63K | |
28-Feb-19 4:59 PM View: | RTI Biologics, Inc. (RTIX) | 28-Feb-19 | Payment of Exercise | 6,097 | $4.98 | $30,363.10 | (2%) 319.73K to 313.63K | 4% |
28-Feb-19 11:22 AM View: | RTI Biologics, Inc. (RTIX) | 26-Feb-19 | Grant | 54,883 | -- | -- | 21% 264.84K to 319.73K | |
13-Dec-18 12:27 PM View: | RTI Biologics, Inc. (RTIX) | 12-Dec-18 | Market Purchase | 50,000 | $4.28 | $214,000.00 | 23% 214.84K to 264.84K | 12% |
02-Mar-18 11:07 AM View: | RTI Biologics, Inc. (RTIX) | 28-Feb-18 | Grant | 58,200 | -- | -- | 37% 156.64K to 214.84K | |
20-Sep-17 11:42 AM View: | RTI Biologics, Inc. (RTIX) | 18-Sep-17 | Grant | 109,890 | -- | -- | 235% 46.75K to 156.64K | |
17-May-17 3:00 PM View: | RTI Biologics, Inc. (RTIX) | 16-May-17 | Grant | 16,484 | -- | -- | 54% 30.27K to 46.75K | |
06-Mar-17 1:22 PM View: | RTI Biologics, Inc. (RTIX) | 02-Mar-17 | Market Purchase | 10,000 | $3.79 | $37,900.00 | 49% 20.27K to 30.27K | 26% |
31-Aug-16 6:25 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 29-Aug-16 | Disposition | 30,871 | $21.75 | $671,444.00 | (80%) 38.73K to 7.86K | (< 1%) |
31-Aug-16 6:25 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 29-Aug-16 | Disposition (change in control) | 7,857 | $21.75 | $170,890.00 | (100%) 7.86K to 0 | (< 1%) |
08-Jul-16 10:20 AM View: | RTI Biologics, Inc. (RTIX) | 06-Jul-16 | Grant | 20,270 | -- | -- | 100% 0 to 20.27K | |
25-Feb-16 6:26 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 25-Feb-16 | Payment of Exercise | 334 | $14.58 | $4,869.72 | (< 1%) 39.06K to 38.73K | 1% |
23-Feb-16 5:54 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 22-Feb-16 | Grant | 16,427 | -- | -- | 71% 23.1K to 39.53K | |
23-Feb-16 5:54 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 22-Feb-16 | Payment of Exercise | 468 | $14.61 | $6,837.48 | (1%) 39.53K to 39.06K | (1%) |
23-Feb-16 5:54 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 21-Feb-16 | Payment of Exercise | 637 | $14.61 | $9,306.57 | (3%) 23.74K to 23.1K | (1%) |
22-Feb-16 12:40 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 18-Feb-16 | Payment of Exercise | 542 | $15.16 | $8,216.72 | (2%) 24.28K to 23.74K | 4% |
05-Jan-16 3:34 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 31-Dec-15 | Payment of Exercise | 853 | $15.85 | $13,520.10 | (3%) 25.14K to 24.28K | 3% |
01-Apr-15 12:32 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 30-Mar-15 | Grant | 5,480 | -- | -- | 28% 19.66K to 25.14K | |
27-Feb-15 3:59 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 25-Feb-15 | Grant | 4,420 | -- | -- | 29% 15.23K to 19.66K | |
24-Feb-15 6:10 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 22-Feb-15 | Payment of Exercise | 395 | $28.50 | $11,257.50 | (3%) 15.63K to 15.23K | 45% |
24-Feb-15 6:10 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 21-Feb-15 | Payment of Exercise | 586 | $28.50 | $16,701.00 | (4%) 16.22K to 15.63K | 45% |
20-Feb-15 4:39 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 18-Feb-15 | Payment of Exercise | 542 | $27.22 | $14,753.20 | (3%) 16.76K to 16.22K | 42% |
24-Feb-14 9:43 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 22-Feb-14 | Payment of Exercise | 423 | $21.75 | $9,200.25 | (2%) 17.18K to 16.76K | 28% |
24-Feb-14 9:43 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 21-Feb-14 | Payment of Exercise | 566 | $21.84 | $12,361.40 | (3%) 17.75K to 17.18K | 28% |
19-Feb-14 9:14 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 18-Feb-14 | Grant | 5,952 | -- | -- | 50% 11.79K to 17.75K | |
02-Jan-14 3:33 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 22-Feb-13 | Payment of Exercise | 416 | $16.85 | $7,009.60 | (3%) 12.21K to 11.79K | 7% |
25-Feb-13 8:07 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 21-Feb-13 | Grant | 6,991 | -- | -- | 134% 5.22K to 12.21K | |
24-Feb-12 8:00 PM View: | Sagent Pharmaceuticals, Inc. (SGNT) | 22-Feb-12 | Grant | 5,220 | -- | -- | 100% 0 to 5.22K | |
11-May-11 11:19 AM View: | Landauer Inc. (LDR) | 09-May-11 | Market Sale | 2,581 | $60.05 | $154,989.00 | (14%) 18.15K to 15.57K | (41%) |
19-Apr-11 3:23 PM View: | Landauer Inc. (LDR) | 19-Apr-11 | Payment of Exercise | 1,169 | $61.88 | $72,337.70 | (6%) 19.32K to 18.15K | (37%) |
17-Nov-10 10:10 AM View: | Landauer Inc. (LDR) | 16-Nov-10 | Grant | 1,305 | -- | -- | 7% 18.02K to 19.32K | |
13-Jan-10 4:23 PM View: | Landauer Inc. (LDR) | 12-Jan-10 | Grant | 1,372 | -- | -- | 8% 16.64K to 18.02K | |
11-Dec-09 6:06 PM View: | Landauer Inc. (LDR) | 10-Dec-09 | Grant | 2,345 | $54.69 | $128,248.00 | 16% 14.3K to 16.64K | |
27-Oct-09 12:56 PM View: | Landauer Inc. (LDR) | 26-Oct-09 | Payment of Exercise | 192 | $55.50 | $10,656.00 | (1%) 14.49K to 14.3K | (64%) |
07-Oct-09 2:46 PM View: | Landauer Inc. (LDR) | 06-Oct-09 | Payment of Exercise | 1,173 | $54.69 | $64,151.40 | (7%) 15.66K to 14.49K | (67%) |
17-Apr-09 3:12 PM View: | Landauer Inc. (LDR) | 15-Apr-09 | Grant | 8,656 | -- | -- | 124% 7.01K to 15.66K | |
09-Feb-09 5:22 PM View: | Landauer Inc. (LDR) | 06-Feb-09 | Grant | 1,373 | -- | -- | 24% 5.63K to 7.01K | |
20-Oct-08 1:40 PM View: | Landauer Inc. (LDR) | 20-Oct-08 | Payment of Exercise | 222 | $58.14 | $12,907.10 | (4%) 5.86K to 5.63K | (54%) |
03-Oct-08 4:13 PM View: | Landauer Inc. (LDR) | 02-Oct-08 | Payment of Exercise | 679 | $71.17 | $48,324.40 | (10%) 6.54K to 5.86K | (27%) |
10-Sep-08 3:43 PM View: | Landauer Inc. (LDR) | 09-Sep-08 | Disposition | 1,527 | -- | -- | (19%) 8.06K to 6.54K | |
08-May-08 1:41 PM View: | Landauer Inc. (LDR) | 07-May-08 | Payment of Exercise | 189 | $53.38 | $10,087.90 | (2%) 8.25K to 8.06K | (72%) |